Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Current Leases (2016 - 2025)

Outlook Therapeutics (OTLK) has disclosed Current Leases for 8 consecutive years, with $61125.0 as the latest value for Q4 2025.

  • Quarterly Current Leases rose 16.11% to $61125.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $61125.0 through Dec 2025, up 16.11% year-over-year, with the annual reading at $58897.0 for FY2025, N/A changed from the prior year.
  • Current Leases for Q4 2025 was $61125.0 at Outlook Therapeutics, up from $58897.0 in the prior quarter.
  • The five-year high for Current Leases was $61125.0 in Q4 2025, with the low at $52645.0 in Q4 2024.